Skip to main content
. 2012 Mar;81(3):440–454. doi: 10.1124/mol.111.077040

TABLE 2.

Residues within the PC1/3 binding pocket predicted to be in contact with the most potent PC1/3 inhibitors

Residues within 2 Å are shown in bold.

166631 His93, Leu126, Val130, Glu135, Ser152, Trp153, Gly154, Pro155, Asn156, Asp157, Glu163, Gly164, Ala191, Ser192, Gly193, Asn194, Asp205, Tyr207, Thr208, Ser267
166550 Glu90, Leu126, Gly128, Val130, Glu135, Trp153, Gly154, Pro155, Asn156, Asp157, Glu163, Gly164, Ala191, Gly193, Asn194, Asp205, Tyr207
166811 His93, Leu126, Val130, Glu135, Ser152, Trp153, Gly154, Pro155, Asn156, Asp157, Glu163, Gly164, Ala191, Gly193, Asn194, Asp205, Tyr207, Ser267
166812 His93, Leu126, Val130, Glu135, Ser152, Trp153, Gly154, Pro155, Asn156, Asp157, Glu163, Gly164, Ala191, Ser192, Gly193, Asn194, Asp205, Tyr207, Thr208, Ser267